S 5 110th Congress Senate Health Administrative procedure Congress Congressional reporting requirements Cytology Department of Health and Human Services Donation of organs, tissues, etc. Economics and Public Finance Federal aid to research Genetic research Genetics Government Operations and Politics Human embryology In vitro fertilization Informed consent (Medical law) Law Medical ethics Medical research Research grants Science, Technology, Communications

Stem Cell Research Enhancement Act of 2007

Introduced: January 4, 2007 See on congress.gov

Everywhere this bill has been 30 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jun 20, 2007

Vetoed by President. (text of veto message: CR S8060-8061)

Jun 20, 2007

Veto message received in Senate. Ordered held at the desk.

Jun 20, 2007

Vetoed by President.(text of veto message: CR S8060-8061)

Jun 12, 2007

Presented to President.

Jun 7, 2007

On passage Passed by the Yeas and Nays: 247 - 176 (Roll no. 443). (text: CR H6125)

Jun 7, 2007

On motion to commit with instructions Failed by the Yeas and Nays: 180 - 242 (Roll no. 442).

Jun 7, 2007

The previous question on the motion to commit with instructions was ordered without objection. (consideration: CR H6142-6143; text: H6141)

Jun 7, 2007

DEBATE - The House proceeded with 10 minutes of debate on the Gingrey motion to commit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment in the nature of a substitute inserting a complete new text entitled "Alternative Pluripotent Stem Cell Therapies Enhancement Act of 2007."

Jun 7, 2007

Mr. Gingrey moved to commit with instructions to Energy and Commerce. (consideration: CR H6141-6142)

Jun 7, 2007

The previous question was ordered pursuant to the rule. (consideration: CR H6141)

Jun 7, 2007

DEBATE - The House proceeded with one hour of debate on S. 5.

Jun 7, 2007

Rule provides for consideration of S. 5 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions. Measure will be considered read. Bill is closed to amendments. All points of order against the bill and against its consideration are waived except those arising under clause 10 of rule XXI. A motion to commit is in order.

Jun 7, 2007

Rule H. Res. 464 passed House.

Jun 7, 2007

Considered under the provisions of rule H. Res. 464. (consideration: CR H6125-6143)

Jun 7, 2007

Passed/agreed to in House: On passage Passed by the Yeas and Nays: 247 - 176 (Roll no. 443).(text: CR H6125)

Jun 7, 2007

Cleared for White House.

Jun 7, 2007

Motion to reconsider laid on the table Agreed to without objection.

Jun 6, 2007

Rules Committee Resolution H. Res. 464 Reported to House. Rule provides for consideration of S. 5 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions. Measure will be considered read. Bill is closed to amendments. All points of order against the bill and against its consideration are waived except those arising under clause 10 of rule XXI. A motion to commit is in order.

Apr 16, 2007

Held at the desk.

Apr 16, 2007

Received in the House.

Apr 12, 2007

Message on Senate action sent to the House.

Apr 11, 2007

Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 63 - 34. Record Vote Number: 127. (text as passed Senate: CR S4389-4390)

Apr 11, 2007

Passed/agreed to in Senate: Passed Senate, having acquired the 60 votes required under unanimous consent, without amendment by Yea-Nay Vote. 63 - 34. Record Vote Number: 127.(text as passed Senate: CR S4389-4390)

Apr 11, 2007

Considered by Senate. (consideration: CR S4319-4371, S4386-4391)

Apr 10, 2007

Measure laid before Senate by unanimous consent. (consideration: CR S4237-4294)

Mar 29, 2007

Star Print ordered on on the bill.

Jan 8, 2007

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 3.

Jan 4, 2007

Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

Jan 4, 2007

Sponsor introductory remarks on measure. (CR S9-11)

Jan 4, 2007

Introduced in Senate

Votes taken on this bill 2

Date	Chamber	What was voted on	Result	Yes–No
Jun 7, 2007	House · vote #443	On Passage	Passed	247–176	See who voted →
Jun 7, 2007	House · vote #442	On Motion to Commit with Instructions	Failed	180–242	See who voted →

Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The expanded summary of the Senate passed version is repeated here.)

Stem Cell Research Enhancement Act of 2007 - (Sec. 2) Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements.

Directs the Secretary to: (1) issue final guidelines to carry out this Act within 60 days; and (2) submit annual reports on activities and research conducted under this Act.

(Sec. 3) Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

Sets forth reporting requirements.

Authorizes appropriations.

What's happening now June 20, 2007

Veto message received in Senate. Ordered held at the desk.

Cosponsors 7